- Home
- ABT vs MRK Comparison
ABT vs MRK Comparison
Compare ABT & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- MRK
- Stock Information
- Founded
- ABT 1888
- MRK 2000
- Country
- ABT United States
- MRK United States
- Employees
- ABT N/A
- MRK N/A
- Industry
- ABT Medical/Dental Instruments
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ABT Health Care
- MRK Health Care
- Exchange
- ABT Nasdaq
- MRK Nasdaq
- Market Cap
- ABT 221.0B
- MRK 218.2B
- IPO Year
- ABT N/A
- MRK N/A
- Fundamental
- Price
- ABT $134.78
- MRK $76.06
- Analyst Decision
- ABT Buy
- MRK Buy
- Analyst Count
- ABT 18
- MRK 15
- Target Price
- ABT $140.44
- MRK $113.71
- AVG Volume (30 Days)
- ABT 6.3M
- MRK 16.2M
- Earning Date
- ABT 04-16-2025
- MRK 04-24-2025
- Dividend Yield
- ABT 1.75%
- MRK 4.26%
- EPS Growth
- ABT 139.92
- MRK 667.14
- EPS
- ABT 7.70
- MRK 6.88
- Revenue
- ABT $42,344,000,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- ABT $7.26
- MRK $2.51
- Revenue Next Year
- ABT $7.96
- MRK $5.75
- P/E Ratio
- ABT $17.50
- MRK $11.06
- Revenue Growth
- ABT 5.00
- MRK 4.10
- 52 Week Low
- ABT $99.71
- MRK $75.93
- 52 Week High
- ABT $141.23
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- ABT 59.88
- MRK 41.05
- Support Level
- ABT $128.19
- MRK $73.31
- Resistance Level
- ABT $135.22
- MRK $81.27
- Average True Range (ATR)
- ABT 2.85
- MRK 2.47
- MACD
- ABT 0.09
- MRK -0.36
- Stochastic Oscillator
- ABT 77.05
- MRK 21.96
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.